Inactive Instrument

Highlights Helius Medical Technologies, Inc. Toronto S.E.

Equities

HSM

US42328V6039

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center	Apr. 24	CI
Top Premarket Gainers	Apr. 03	MT
Helius Medical Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Helius Medical Technologies, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 28	CI
Earnings Flash (HSDT) HELIUS MEDICAL TECHNOLOGIES Reports Q4 Revenue $134,000	Mar. 28	MT
Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke	Mar. 12	CI
Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller	Mar. 04	CI
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Tuesday as Earnings Flow Intensifies	Feb. 06	MT
Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients	Feb. 06	CI
Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital	Jan. 11	CI
Earnings Flash (HSDT) HELIUS MEDICAL TECHNOLOGIES Reports Q3 Revenue $143,000	Nov. 09	MT
Earnings Flash (HSDT) HELIUS MEDICAL TECHNOLOGIES Reports Q3 Revenue $143,000	Nov. 09	MT
Helius Medical Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Helius Medical Technologies, Inc. Announces Study Results Demonstrating That PoNS Therapy(TM) Helps Patients with Traumatic Brain Injury Return to Work	Nov. 06	CI
Helius Medical Technologies, Inc. Provides Financial Guidance for the Third Quarter of 2023	Nov. 02	CI
Helius Medical Technologies, Inc. Receives Letter of Intent from Québec Ministry of Health and Social Services to Purchase 30 PoNS Devices	23-10-12	CI
Helius Medical Technologies, Inc. Signs an Agreement with the School of Rehabilitation at the University of Montreal	23-09-20	CI
Helius Medical Technologies Regains Compliance With Nasdaq Minimum Bid Price Rule; Shares Rise	23-09-05	MT
Earnings Flash (HSDT) HELIUS MEDICAL TECHNOLOGIES Reports Q2 Revenue $256,000	23-08-10	MT
Helius Medical Technologies, Inc. Provides Earnings Guidance for the Third Quarter and Full Year of 2023	23-08-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Helius Medical Technologies, Inc. Toronto S.E.

Equities

HSM

US42328V6039

Highlights

Filters